Foley N M, Coral A P, Tung K, Hudspith B N, James D G, Johnson N M
Medical Unit, Middlesex Hospital, London.
Thorax. 1989 Sep;44(9):732-8. doi: 10.1136/thx.44.9.732.
Sixty seven patients with biopsy proven pulmonary sarcoidosis were prospectively studied to determine whether single point bronchoalveolar lavage cell counts were a useful indicator of functional outcome and whether repeated lavage helped in management. The mean follow up period was 25 (range 13-37) months. No patient was having corticosteroid treatment at the time of initial bronchoalveolar lavage. "High intensity alveolitis" (lymphocyte count greater than or equal to 28%) was present at the initial lavage in 42 patients. These patients showed a significant improvement in their pulmonary function and chest radiographs over the follow up period whereas patients with "low intensity alveolitis" did not. Of the 42 patients with high intensity alveolitis, 31 had chronic sarcoidosis (duration over two years, mean 80 months). These patients showed a significant improvement in FVC but not in TLCO. Corticosteroids resulted in greater functional and radiological improvement in the patients with high intensity alveolitis than in those with low intensity alveolitis. Repeat bronchoalveolar lavage in 34 patients, mean 8.4 months after the original lavage, showed a weak inverse relation between a reduced lymphocyte count and change in forced vital capacity and isotope uptake on a gallium scan. These correlations were too weak to make repeated cell counts useful in management. Our results suggest that high intensity alveolitis may be a favourable prognostic factor for lung function in pulmonary sarcoidosis, even in patients with chronic disease, but that repeat lavage adds little to the management of the individual patient.
对67例经活检证实为肺结节病的患者进行了前瞻性研究,以确定单点支气管肺泡灌洗细胞计数是否是功能预后的有用指标,以及重复灌洗是否有助于治疗。平均随访期为25个月(范围13 - 37个月)。在初次支气管肺泡灌洗时,没有患者正在接受皮质类固醇治疗。42例患者在初次灌洗时出现“高强度肺泡炎”(淋巴细胞计数大于或等于28%)。在随访期间,这些患者的肺功能和胸部X线片有显著改善,而“低强度肺泡炎”患者则没有。在42例高强度肺泡炎患者中,31例患有慢性结节病(病程超过两年,平均80个月)。这些患者的用力肺活量(FVC)有显著改善,但肺一氧化碳弥散量(TLCO)没有改善。与低强度肺泡炎患者相比,皮质类固醇治疗使高强度肺泡炎患者在功能和影像学方面有更大的改善。34例患者在初次灌洗平均8.4个月后进行重复支气管肺泡灌洗,结果显示淋巴细胞计数减少与用力肺活量变化及镓扫描同位素摄取之间存在微弱的负相关。这些相关性太弱,以至于重复细胞计数对治疗没有帮助。我们的结果表明,即使在患有慢性疾病的患者中,高强度肺泡炎可能是肺结节病肺功能的一个有利预后因素,但重复灌洗对个体患者的治疗帮助不大。